• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过使用氯尼达明和热疗增强阿霉素对P388小鼠白血病敏感株和耐药株的细胞毒性。

Potentiation of adriamycin cytotoxicity in P388 murine leukemia sensitive and resistant to adriamycin by use of lonidamine and hyperthermia.

作者信息

Chitnis M, Adwankar M

出版信息

Tumori. 1986 Oct 31;72(5):469-73. doi: 10.1177/030089168607200503.

DOI:10.1177/030089168607200503
PMID:3798566
Abstract

The in vitro effect of adriamycin (ADR) and lonidamine alone and in combination, at 37 degrees C and 43 degrees C, was investigated on murine leukemia P388 sensitive (P388/S) and resistant (P388/ADR) to adriamycin. The sensitive and the resistant cells were exposed in vitro with and without the drugs for 1 h at 37 degrees C and 43 degrees C. These cells were inoculated ip (10(6) cells/mouse) into groups of BDF1 mice. Cytotoxic effect of the treatment was assessed on the basis of percentage increase in life span (% ILS) of these animals, compared to the animals receiving cells which did not receive any treatment but exposed only to 37 degrees C for 1 h. It was observed that exposure of P388/ADR cells to lonidamine or adriamycin alone at 43 degrees C for 1 h resulted in greater cell kill, thus enhancing the % ILS of the experimental animals receiving those cells, compared to that of mice receiving the cells exposed to the same drugs for 1 h at 37 degrees C. However, the combination of lonidamine (0.02 mM) and adriamycin (10 micrograms/ml) at 43 degrees C for 1 h showed more than a synergistic effect, resulting in a % ILS of 120. Similar results were seen in the case of P388/S; however, the observations pertaining to P388/ADR are encouraging, since the mode of treatment has reversed the acquired resistance of P388 leukemia cells to adriamycin.

摘要

研究了阿霉素(ADR)和氯尼达明单独及联合使用在37℃和43℃时对阿霉素敏感(P388/S)和耐药(P388/ADR)的小鼠白血病细胞的体外作用。将敏感和耐药细胞在有或无药物的情况下于37℃和43℃体外暴露1小时。将这些细胞腹腔注射(10⁶个细胞/小鼠)到BDF1小鼠组中。根据这些动物的寿命延长百分比(%ILS)评估治疗的细胞毒性作用,并与接受未接受任何治疗但仅在37℃暴露1小时的细胞的动物进行比较。观察到,将P388/ADR细胞在43℃单独暴露于氯尼达明或阿霉素1小时导致更大的细胞杀伤,因此与接受在37℃暴露于相同药物1小时的细胞的小鼠相比,接受这些细胞的实验动物的%ILS有所提高。然而,氯尼达明(0.02 mM)和阿霉素(10微克/毫升)在43℃联合作用1小时显示出超过协同效应,导致%ILS达到120。在P388/S细胞中也观察到类似结果;然而,与P388/ADR相关的观察结果令人鼓舞,因为这种治疗方式逆转了P388白血病细胞对阿霉素的获得性耐药。

相似文献

1
Potentiation of adriamycin cytotoxicity in P388 murine leukemia sensitive and resistant to adriamycin by use of lonidamine and hyperthermia.通过使用氯尼达明和热疗增强阿霉素对P388小鼠白血病敏感株和耐药株的细胞毒性。
Tumori. 1986 Oct 31;72(5):469-73. doi: 10.1177/030089168607200503.
2
Modification of tumor cell sensitivity to antineoplastic agents lonidamine and bouvardin (NSC 259968) at elevated temperatures.
Neoplasma. 1986;33(2):217-23.
3
Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.对阿霉素的耐药性:阿霉素敏感和耐药的P388白血病克隆细胞系中细胞毒性与药物摄取及DNA单链和双链断裂的关系。
Cancer Res. 1986 Jun;46(6):2978-83.
4
Evaluation of quinidine effect on the antitumor activity of adriamycin and mitoxantrone in adriamycin-sensitive and -resistant P388 leukemia cells.
Sel Cancer Ther. 1990 Summer;6(2):93-102. doi: 10.1089/sct.1990.6.93.
5
Differential agglutination of P388 adriamycin-sensitive and P388 adriamycin-resistant leukemia cells.
Oncology. 1983;40(3):202-4. doi: 10.1159/000225726.
6
Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.钙调蛋白抑制剂三氟拉嗪增强耐药P388白血病对阿霉素的敏感性
Cancer Res. 1983 Aug;43(8):3696-9.
7
Circumvention of drug resistance of P388/R cells by the combination of adriamycin and mitoxantrone with hyperthermia (42 degrees C).
Neoplasma. 1991;38(2):207-11.
8
Restoration of drug sensitivity by nitroxazepine hydrochloride in P388 murine leukemia cells resistant to adriamycin.
Cancer Drug Deliv. 1987 Spring;4(1):1-9. doi: 10.1089/cdd.1987.4.1.
9
Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells.阿霉素敏感和阿霉素耐药的P388小鼠白血病细胞中的细胞内阿霉素水平及细胞毒性
J Natl Cancer Inst. 1982 Jun;68(6):1027-32.
10
Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells by dipyrone.通过双嘧达莫恢复多柔比星耐药的P388小鼠白血病细胞对多柔比星的反应性。
Oncology. 1987;44(1):47-50. doi: 10.1159/000226442.

引用本文的文献

1
Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts.刺激凋亡反应作为氯尼达明与顺铂联合治疗人肿瘤异种移植瘤协同作用的基础。
Br J Cancer. 1998;77(3):434-9. doi: 10.1038/bjc.1998.69.
2
Phase II study of lonidamine in metastatic breast cancer.氯尼达明治疗转移性乳腺癌的II期研究。
Br J Cancer. 1989 Feb;59(2):251-3. doi: 10.1038/bjc.1989.51.
3
In vitro potentiation by lonidamine of the cytotoxic effect of adriamycin on primary and established breast cancer cell lines.
氯尼达明对阿霉素在原发性和已建立的乳腺癌细胞系上细胞毒性作用的体外增强作用。
Breast Cancer Res Treat. 1992;24(1):27-34. doi: 10.1007/BF01832355.